Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Analysis of S6 (pS235/pS236) in activated human peripheral blood mononuclear cells (PBMC). PBMC were isolated by density gradient centrifugation (Ficoll-Paque™ PLUS, Cat. No. 17-1440-02) and either left untreated (open histogram) or treated with PMA (Sigma-Aldrich, Cat. No. P8139) at 50 nM/10^6 cells for 30 minutes (shaded histogram). Cells were then fixed in BD Cytofix™ buffer (Cat. No. 554655) at 37°C for 10 minutes, then permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050) on ice for at least 30 minutes, and then stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of S6 (pS235/pS236) in activated human peripheral blood mononuclear cells (PBMC). PBMC were isolated by density gradient centrifugation (Ficoll-Paque™ PLUS, Cat. No. 17-1440-02) and either left untreated (open histogram) or treated with PMA (Sigma-Aldrich, Cat. No. P8139) at 50 nM/10^6 cells for 30 minutes (shaded histogram). Cells were then fixed in BD Cytofix™ buffer (Cat. No. 554655) at 37°C for 10 minutes, then permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050) on ice for at least 30 minutes, and then stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Immunofluorescent staining of human cell line. HeLa cells (ATCC CCL-2) were seeded in a 96-well imaging plate (Cat. No. 353219) at ~10,000 cells per well. After overnight serum starvation, some wells were cultured for 30 minutes with 20% fetal bovine serum (FBS, top panel) and others were not (lower panel). The cells were fixed with BD Cytofix™ buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236) (psedocolored magenta), and the nuclei were counterstained with Hoechst 33342 (pseudo colored blue). The images were captured on a BD Pathway™ 435 High-Content Bioimager System with a 20x objective and merged using BD Attovision™ software. The staining worked with the cold methanol and the Triton X-100 Perm/Wash protocols.
Western blot analysis of S6 (pS235/pS236). The specificity of mAb N7-548 was confirmed by western blot analysis using unconjugated Mouse anti-S6 (pS235/pS236) antibody on lysates from untreated (lane 1) or PMA-treated (lane 2) PBMC. S6 (pS235/pS236) is identified as a band of 32 kDa, with increased intensity in the PMA-treated cells. Purified Mouse anti-Actin monoclonal antibody (Cat. No. 612656 or 612657) was the gel-loading control.
Western blot analysis of S6 (pS235/pS236). The specificity of mAb N7-548 was confirmed by western blot analysis using unconjugated Mouse anti-S6 (pS235/pS236) antibody on lysates from untreated (lane 1) or PMA-treated (lane 2) PBMC. S6 (pS235/pS236) is identified as a band of 32 kDa, with increased intensity in the PMA-treated cells. Purified Mouse anti-Actin monoclonal antibody (Cat. No. 612656 or 612657) was the gel-loading control.
Immunofluorescent staining of human cell line. HeLa cells (ATCC CCL-2) were seeded in a 96-well imaging plate (Cat. No. 353219) at ~10,000 cells per well. After overnight serum starvation, some wells were cultured for 30 minutes with 20% fetal bovine serum (FBS, top panel) and others were not (lower panel). The cells were fixed with BD Cytofix™ buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236) (psedocolored magenta), and the nuclei were counterstained with Hoechst 33342 (pseudo colored blue). The images were captured on a BD Pathway™ 435 High-Content Bioimager System with a 20x objective and merged using BD Attovision™ software. The staining worked with the cold methanol and the Triton X-100 Perm/Wash protocols.
Analysis of S6 (pS235/pS236) in activated human peripheral blood mononuclear cells (PBMC). PBMC were isolated by density gradient centrifugation (Ficoll-Paque™ PLUS, Cat. No. 17-1440-02) and either left untreated (open histogram) or treated with PMA (Sigma-Aldrich, Cat. No. P8139) at 50 nM/10^6 cells for 30 minutes (shaded histogram). Cells were then fixed in BD Cytofix™ buffer (Cat. No. 554655) at 37°C for 10 minutes, then permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050) on ice for at least 30 minutes, and then stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of S6 (pS235/pS236) in activated human peripheral blood mononuclear cells (PBMC). PBMC were isolated by density gradient centrifugation (Ficoll-Paque™ PLUS, Cat. No. 17-1440-02) and either left untreated (open histogram) or treated with PMA (Sigma-Aldrich, Cat. No. P8139) at 50 nM/10^6 cells for 30 minutes (shaded histogram). Cells were then fixed in BD Cytofix™ buffer (Cat. No. 554655) at 37°C for 10 minutes, then permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050) on ice for at least 30 minutes, and then stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Immunofluorescent staining of human cell line. HeLa cells (ATCC CCL-2) were seeded in a 96-well imaging plate (Cat. No. 353219) at ~10,000 cells per well. After overnight serum starvation, some wells were cultured for 30 minutes with 20% fetal bovine serum (FBS, top panel) and others were not (lower panel). The cells were fixed with BD Cytofix™ buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236) (psedocolored magenta), and the nuclei were counterstained with Hoechst 33342 (pseudo colored blue). The images were captured on a BD Pathway™ 435 High-Content Bioimager System with a 20x objective and merged using BD Attovision™ software. The staining worked with the cold methanol and the Triton X-100 Perm/Wash protocols.
Western blot analysis of S6 (pS235/pS236). The specificity of mAb N7-548 was confirmed by western blot analysis using unconjugated Mouse anti-S6 (pS235/pS236) antibody on lysates from untreated (lane 1) or PMA-treated (lane 2) PBMC. S6 (pS235/pS236) is identified as a band of 32 kDa, with increased intensity in the PMA-treated cells. Purified Mouse anti-Actin monoclonal antibody (Cat. No. 612656 or 612657) was the gel-loading control.
Western blot analysis of S6 (pS235/pS236). The specificity of mAb N7-548 was confirmed by western blot analysis using unconjugated Mouse anti-S6 (pS235/pS236) antibody on lysates from untreated (lane 1) or PMA-treated (lane 2) PBMC. S6 (pS235/pS236) is identified as a band of 32 kDa, with increased intensity in the PMA-treated cells. Purified Mouse anti-Actin monoclonal antibody (Cat. No. 612656 or 612657) was the gel-loading control.
Immunofluorescent staining of human cell line. HeLa cells (ATCC CCL-2) were seeded in a 96-well imaging plate (Cat. No. 353219) at ~10,000 cells per well. After overnight serum starvation, some wells were cultured for 30 minutes with 20% fetal bovine serum (FBS, top panel) and others were not (lower panel). The cells were fixed with BD Cytofix™ buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236) (psedocolored magenta), and the nuclei were counterstained with Hoechst 33342 (pseudo colored blue). The images were captured on a BD Pathway™ 435 High-Content Bioimager System with a 20x objective and merged using BD Attovision™ software. The staining worked with the cold methanol and the Triton X-100 Perm/Wash protocols.
Analysis of S6 (pS235/pS236) in activated human peripheral blood mononuclear cells (PBMC). PBMC were isolated by density gradient centrifugation (Ficoll-Paque™ PLUS, Cat. No. 17-1440-02) and either left untreated (open histogram) or treated with PMA (Sigma-Aldrich, Cat. No. P8139) at 50 nM/10^6 cells for 30 minutes (shaded histogram). Cells were then fixed in BD Cytofix™ buffer (Cat. No. 554655) at 37°C for 10 minutes, then permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050) on ice for at least 30 minutes, and then stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of S6 (pS235/pS236) in activated human peripheral blood mononuclear cells (PBMC). PBMC were isolated by density gradient centrifugation (Ficoll-Paque™ PLUS, Cat. No. 17-1440-02) and either left untreated (open histogram) or treated with PMA (Sigma-Aldrich, Cat. No. P8139) at 50 nM/10^6 cells for 30 minutes (shaded histogram). Cells were then fixed in BD Cytofix™ buffer (Cat. No. 554655) at 37°C for 10 minutes, then permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050) on ice for at least 30 minutes, and then stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Immunofluorescent staining of human cell line. HeLa cells (ATCC CCL-2) were seeded in a 96-well imaging plate (Cat. No. 353219) at ~10,000 cells per well. After overnight serum starvation, some wells were cultured for 30 minutes with 20% fetal bovine serum (FBS, top panel) and others were not (lower panel). The cells were fixed with BD Cytofix™ buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236) (psedocolored magenta), and the nuclei were counterstained with Hoechst 33342 (pseudo colored blue). The images were captured on a BD Pathway™ 435 High-Content Bioimager System with a 20x objective and merged using BD Attovision™ software. The staining worked with the cold methanol and the Triton X-100 Perm/Wash protocols.
Western blot analysis of S6 (pS235/pS236). The specificity of mAb N7-548 was confirmed by western blot analysis using unconjugated Mouse anti-S6 (pS235/pS236) antibody on lysates from untreated (lane 1) or PMA-treated (lane 2) PBMC. S6 (pS235/pS236) is identified as a band of 32 kDa, with increased intensity in the PMA-treated cells. Purified Mouse anti-Actin monoclonal antibody (Cat. No. 612656 or 612657) was the gel-loading control.
Western blot analysis of S6 (pS235/pS236). The specificity of mAb N7-548 was confirmed by western blot analysis using unconjugated Mouse anti-S6 (pS235/pS236) antibody on lysates from untreated (lane 1) or PMA-treated (lane 2) PBMC. S6 (pS235/pS236) is identified as a band of 32 kDa, with increased intensity in the PMA-treated cells. Purified Mouse anti-Actin monoclonal antibody (Cat. No. 612656 or 612657) was the gel-loading control.
Immunofluorescent staining of human cell line. HeLa cells (ATCC CCL-2) were seeded in a 96-well imaging plate (Cat. No. 353219) at ~10,000 cells per well. After overnight serum starvation, some wells were cultured for 30 minutes with 20% fetal bovine serum (FBS, top panel) and others were not (lower panel). The cells were fixed with BD Cytofix™ buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), stained with Alexa Fluor® 647 Mouse anti-S6 (pS235/pS236) (psedocolored magenta), and the nuclei were counterstained with Hoechst 33342 (pseudo colored blue). The images were captured on a BD Pathway™ 435 High-Content Bioimager System with a 20x objective and merged using BD Attovision™ software. The staining worked with the cold methanol and the Triton X-100 Perm/Wash protocols.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Ribosomal protein S6 (~29 kDa calculated and ~32 kDa observed molecular weights) is a component of the 40S ribosomal subunit and belongs to the S6E family of ribosomal proteins. The S6 ribosomal protein plays a role in regulating the translation of RNAs and thus controlling the growth and proliferation of cells. S6 ribosomal protein phosphorylation, especially at multiple C-terminal serine residues S235, S236, S240, and S244, activates S6. The activated S6 ribosomal protein in turn upregulates the ribosomal translation of RNA species coding for other ribosomal proteins, peptide elongation factors and other proteins involved in cell cycle entry and progression. These phosphorylations are mediated by various kinases (e.g., p70S6K and PKCD) activated through cellular responses to growth factors, cytokines, tumor promoting agents, and mitogens. The S6 ribosomal protein can be dephosphorylated in growth-arrested cells.
The N7-548 monoclonal antibody specifically detects the S6 ribosomal protein phosphorylated at S235 and S236.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.